品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | L126135-5mg | 5mg | 现货 | 700874-71-1 |
LY2109761 LY2109761 |
Moligand™, ≥99% |
|
|
阿拉丁 | L126135-10mg | 10mg | 现货 | 700874-71-1 |
LY2109761 LY2109761 |
Moligand™, ≥99% |
|
|
阿拉丁 | L126135-50mg | 50mg | 现货 | 700874-71-1 |
LY2109761 LY2109761 |
Moligand™, ≥99% |
|
|
阿拉丁 | L408237-1ml | 1ml | 现货 | 700874-71-1 |
LY2109761 LY2109761 |
Moligand™, 2mM in DMSO |
|
|
麦克林 | L864678-5mg | 5mg | 订前询问 | 700874-71-1 |
LY2109761 LY2109761 |
≥99% |
|
|
罗恩 | R029169-10mg | 10mg | 5~7个工作日 | 700874-71-1 |
LY2109761 LY2109761 |
99% |
|
|
罗恩 | R029169-50mg | 50mg | 5~7个工作日 | 700874-71-1 |
LY2109761 LY2109761 |
99% |
|
|
罗恩 | R029169-5mg | 5mg | 5~7个工作日 | 700874-71-1 |
LY2109761 LY2109761 |
99% |
|
|
MARY | MR13102710-10mg | 10mg | 订前咨询 | 700874-71-1 |
LY2109761 LY2109761 |
99% |
|
|
MARY | MR13102710-5mg | 5mg | 订前咨询 | 700874-71-1 |
LY2109761 LY2109761 |
99% |
|
|
MARY | MR13102710-50mg | 50mg | 订前咨询 | 700874-71-1 |
LY2109761 LY2109761 |
99% |
|
|
源叶 | S49933-5mg | 5mg | 现货 | 700874-71-1 |
4-[5,6-二氢-2-(2-吡啶基)-4H-吡咯并[1... LY2109761 |
97% |
|
|
源叶 | S49933-10mg | 10mg | 现货 | 700874-71-1 |
4-[5,6-二氢-2-(2-吡啶基)-4H-吡咯并[1... LY2109761 |
97% |
|
|
源叶 | S49933-50mg | 50mg | 期货,请咨询 | 700874-71-1 |
4-[5,6-二氢-2-(2-吡啶基)-4H-吡咯并[1... LY2109761 |
97% |
|
|
源叶 | T88535-1ml | 1ml | 期货,请咨询 | 700874-71-1 |
LY2109761 LY2109761 |
2mM in DMSO |
|
|
毕得 | BD240863-5mg | 5mg | 现货 | 700874-71-1 |
4-(2-((4-(2-(吡啶-2-基)-5,6-二氢-... 4-(2-((4-(2-(Pyridin-2-yl)-5... |
98% |
|
|
毕得 | BD240863-10mg | 10mg | 现货 | 700874-71-1 |
4-(2-((4-(2-(吡啶-2-基)-5,6-二氢-... 4-(2-((4-(2-(Pyridin-2-yl)-5... |
98% |
|
|
毕得 | BD240863-50mg | 50mg | 现货 | 700874-71-1 |
4-(2-((4-(2-(吡啶-2-基)-5,6-二氢-... 4-(2-((4-(2-(Pyridin-2-yl)-5... |
98% |
|
|
毕得 | BD240863-25mg | 25mg | 现货 | 700874-71-1 |
4-(2-((4-(2-(吡啶-2-基)-5,6-二氢-... 4-(2-((4-(2-(Pyridin-2-yl)-5... |
98% |
|
|
毕得 | BD240863-100mg | 100mg | 现货 | 700874-71-1 |
4-(2-((4-(2-(吡啶-2-基)-5,6-二氢-... 4-(2-((4-(2-(Pyridin-2-yl)-5... |
98% |
|
|